{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"JCO Article Insights: Duvelisib in Patients with Relapsed or Refractory PTCL","description":"In this episode of JCO Article Insights, host Ash Gurumurthi summarizes the article &quot;Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed\/Refractory Peripheral T-Cell Lymphoma,&quot; by Mehta-Shah and colleagues. LINK TO FULL TRANSCRIPT ","author_name":"Journal of Clinical Oncology (JCO) Podcast","author_url":"http:\/\/sites.libsyn.com\/58526","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/42232725\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/00457c\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/42232725"}